RecruitingPhase 2NCT05664815

Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management

Studying Osteonecrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre Hospitalier Universitaire de Besancon
Principal Investigator
Aurélien LOUVRIER, MD, PhD
CHU de Besançon
Intervention
Human Amniotic Membrane(biological)
Enrollment
66 target
Eligibility
18 years · All sexes
Timeline
2023 – 2026

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05664815 on ClinicalTrials.gov

Other trials for Osteonecrosis

Additional recruiting or active studies for the same condition.

See all trials for Osteonecrosis →

← Back to all trials